/Companies

AI-MD

Techstars '24

Blackfalds, CA · 1 known investors

Find your way into AI-MD

Sign up to see every warm intro you have to AI-MD

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the AI-MD team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

AI-MD uses camera-based rPPG biomarker detection to read signals like blood flow, oxygenation, pulse, and stress response from a facial scan, then combines these with lifestyle questions to generate personalized supplement recommendations. It serves consumers seeking data-driven wellness insights and matches their biomarker data to supplement formulations from various wellness brands.

Also known as AI-MD Technologies Inc. · AIMD Technologies Inc.

Investors · 1

Techstarslisted by TechstarsBoulder · $220K

How we know: the Techstars portfolio · open dataset · Top 3000 Accelerator Startups (no YC) 2026-08 · Not right? Tell us

Company profile

researched Sep 2026

AI-MD is a digital wellness company that uses camera-based remote photoplethysmography (rPPG) to measure biomarkers from a facial scan taken with a standard device camera. The scan, described as taking under two minutes and requiring no blood tests or wearables, reads patterns in blood flow, oxygenation, pulse and stress response, and returns a visual summary of the user's current wellness state. Results are combined with short lifestyle questions to match the user to a supplement protocol drawn from supplement formulations offered by wellness brands.

Alongside the consumer-facing scan, AI-MD distributes an SDK that lets third-party developers embed its symptom checker and basic vitals face scan into their own applications. The SDK connects over a cloud API at my.ai-md.com, uses client-specific API keys passed in an Authorization header, and accepts device type, demographics (age, sex assigned at birth, height, weight) and optional free-text symptom descriptions with an onset timestamp. A successful assessment request returns a redirect URL to a hosted face-scan flow plus a session identifier; on completion the user's browser is redirected to a developer-supplied URL carrying a base64-encoded results payload containing measured vitals and, when symptoms were submitted, possible conditions.

Business model

AI-MD operates a consumer scan-to-recommendation flow that matches users to supplement products from third-party wellness brands, and separately licenses an API-key-gated SDK that developers integrate into their own applications for symptom checking and vitals face scanning.

Latest developments

AI-MD publishes SDK documentation covering its symptom checker and basic vitals face scan, available to developers through a cloud connection to its API.

▸Full profile — technology, go-to-market, geography

Technology

The core technology is non-invasive rPPG biomarker detection, which reads changes in blood flow, oxygen and pulse directly from the skin via a device camera, supported across Windows, Linux, Android phones and iPhone. A matching layer maps the resulting biomarker data against supplement formulations, and a symptom analysis component returns possible conditions from a free-text symptom description combined with user demographics. The developer-facing stack is a REST API (my.ai-md.com) with JSON request bodies, hosted scan sessions at scan.ai-md.com, and base64-encoded result payloads returned via redirect.

Go-to-market

Direct-to-consumer via the website's "Scan Yourself" flow, with a 24/7 support function reporting a 6-minute average first response, a 3-hour average resolution time and 96% customer satisfaction; a developer channel operates through documented API access granted after registering with AI-MD for an API key and supplying a redirect URL.

Consumers seeking non-invasive wellness measurement and supplement guidance, plus software developers and application providers who embed AI-MD's symptom checker and vitals face scan through its SDK.

Geography

Offices are listed in Palo Alto, California (AI-MD Technologies Inc., 2100 Geng Rd. Suite 210) and Toronto, Ontario (AIMD Technologies Inc., 180 Bloor St. W).

Compiled by commissioned research from 6 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
Average support resolution timeJan 20263 hours
Average time to first support responseJan 20266 minutes
Customer satisfactionJan 202696%

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Related companies · 2

Companies working in the same space as AI-MD.

▸Research sources · 6

primary sources listed

6 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does AI-MD do?
AI-MD turns a camera-based facial biomarker scan into personalized supplement recommendations and offers a symptom-checker SDK.
Who are AI-MD's investors?
AI-MD's investors include Techstars.
Where is AI-MD headquartered?
AI-MD is headquartered in Blackfalds, CA.